Not Signed In - Increasing Dose Intensity Of Chemotherapy In Osteosarcoma Offers No Benefit Study Finds
Fri, 19 Jan 2007 01:00 PM EST
... A dose-intensive regimen of the chemotherapy drugs cisplatin and doxorubicin offered no clinical benefit over standard doses of the chemotherapy drugs in patients with a bone cancer called osteosarcoma, according to results from a randomized trial in the January 17 issue of the Journal of the National Cancer Institute. [click link for full article] ...
Related Topics
- Chemotherapy
- Side effects of chemotherapy (depending on the type of chemotherapy)
- Carboplatin
- Chondroitin
- Methylprednisolone
- Bone Cancer
- Workout Intensity
- Fluorouracil
- Local spread of the tumor with increasing pain
- Osteosarcoma/Bone Fibrous Histiocytoma
- Malignant Fibrous Histiocytoma of Bone/Osteosarcoma
- Osteosarcoma/Malignant Fibrous Histiocytoma of Bone
- Bone Cancer, Osteosarcoma/Malignant Fibrous Histiocytoma
- Naltrexone
- Emotional Disorders
- Pension
- Radiation Studies
- Hemodialysis Dose and Adequacy
- Metered Dose Inhaler
- Peritoneal Dialysis Dose and Adequacy
email this page
print this page
bookmark this page
feedback on this page
